Acorah Software Products - Accounts Production 19.2.450 false true false true No description of principal activity 4 September 2024 28 February 2026 28 February 2026 15936319 R Nobrega iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15936319 2024-09-03 15936319 2026-02-28 15936319 2024-09-04 2026-02-28 15936319 frs-core:CurrentFinancialInstruments 2026-02-28 15936319 frs-bus:PrivateLimitedCompanyLtd 2024-09-04 2026-02-28 15936319 frs-bus:FilletedAccounts 2024-09-04 2026-02-28 15936319 frs-bus:Micro-entities 2024-09-04 2026-02-28 15936319 frs-bus:AuditExempt-NoAccountantsReport 2024-09-04 2026-02-28 15936319 frs-bus:Director1 2024-09-04 2026-02-28
Registered number: 15936319
London Neurourology Limited
Unaudited Financial Statements
For the Period 4 September 2024 to 28 February 2026
Perrigo Consultants Limited
Balance Sheet
Registered number: 15936319
28 February 2026
£
Fixed assets 1,224
Current assets 38,752
Prepayments and accrued income 1,296
Creditors: Amounts Falling Due Within One Year (49,665 )
NET CURRENT LIABILITIES (9,617 )
TOTAL ASSETS LESS CURRENT LIABILITIES (8,393 )
Accruals and deferred income 8,703
NET ASSETS 310
CAPITAL AND RESERVES 310

Notes

1. General Information
London Neurourology Limited is a private company, limited by shares, incorporated in England & Wales, registered number 15936319 . The registered office is Anglo House, Worcester Road, Stourport On Severn, Worcestershire, DY13 9AW.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 1
1
For the period ending 28 February 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
R Nobrega
Director
18/05/2026